MITOCHONDRIAL ENCEPHALOMYOPATHY, LACTIC ACIDOSIS AND STROKE-LIKE EPISODES (MELAS)
Clinical trials for MITOCHONDRIAL ENCEPHALOMYOPATHY, LACTIC ACIDOSIS AND STROKE-LIKE EPISODES (MELAS) explained in plain language.
Never miss a new study
Get alerted when new MITOCHONDRIAL ENCEPHALOMYOPATHY, LACTIC ACIDOSIS AND STROKE-LIKE EPISODES (MELAS) trials appear
Sign up with your email to follow new studies for MITOCHONDRIAL ENCEPHALOMYOPATHY, LACTIC ACIDOSIS AND STROKE-LIKE EPISODES (MELAS), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for devastating mitochondrial disease
Disease control Recruiting nowThis study is testing whether an oral medicine called TTI-0102 can help control symptoms and improve daily function in people with MELAS, a rare and serious genetic disorder that affects energy production in the body. About 12 participants, aged 16-60 with moderate disease, will …
Matched conditions: MITOCHONDRIAL ENCEPHALOMYOPATHY, LACTIC ACIDOSIS AND STROKE-LIKE EPISODES (MELAS)
Phase: PHASE2 • Sponsor: Thiogenesis Therapeutics, Inc. • Aim: Disease control
Last updated Mar 18, 2026 14:41 UTC
-
Hope for mitochondrial disease patients: new drug targets debilitating fatigue
Symptom relief Recruiting nowThis study is testing whether a medicine called sonlicromanol can reduce fatigue and improve physical abilities like balance and leg strength in adults with a specific type of mitochondrial disease. About 220 participants will take either the real medicine or a placebo pill twice…
Matched conditions: MITOCHONDRIAL ENCEPHALOMYOPATHY, LACTIC ACIDOSIS AND STROKE-LIKE EPISODES (MELAS)
Phase: PHASE3 • Sponsor: Khondrion BV • Aim: Symptom relief
Last updated Mar 30, 2026 14:28 UTC